These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37983238)

  • 1. Oral angiotensin-converting enzyme inhibitor captopril protects the heart from Porphyromonas gingivalis LPS-induced cardiac dysfunction in mice.
    Kiyomoto K; Matsuo I; Suita K; Ohnuki Y; Ishikawa M; Ito A; Mototani Y; Tsunoda M; Morii A; Nariyama M; Hayakawa Y; Amitani Y; Gomi K; Okumura S
    PLoS One; 2023; 18(11):e0292624. PubMed ID: 37983238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of TLR4 signaling on Porphyromonas gingivalis LPS-induced cardiac dysfunction in mice.
    Matsuo I; Kawamura N; Ohnuki Y; Suita K; Ishikawa M; Matsubara T; Mototani Y; Ito A; Hayakawa Y; Nariyama M; Morii A; Kiyomoto K; Tsunoda M; Gomi K; Okumura S
    PLoS One; 2022; 17(6):e0258823. PubMed ID: 35648750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the angiotensin-converting enzyme inhibitor captopril on occlusal-disharmony-induced cardiac dysfunction in mice.
    Ito A; Ohnuki Y; Suita K; Matsuo I; Ishikawa M; Mitsubayashi T; Mototani Y; Kiyomoto K; Tsunoda M; Morii A; Nariyama M; Hayakawa Y; Tomonari H; Okumura S
    Sci Rep; 2023 Nov; 13(1):19927. PubMed ID: 37968296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vidarabine, an anti-herpes agent, improves Porphyromonas gingivalis lipopolysaccharide-induced cardiac dysfunction in mice.
    Tsunoda M; Matsuo I; Ohnuki Y; Suita K; Ishikawa M; Mitsubayashi T; Ito A; Mototani Y; Kiyomoto K; Morii A; Nariyama M; Hayakawa Y; Gomi K; Okumura S
    J Physiol Sci; 2023 Aug; 73(1):18. PubMed ID: 37558983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibition attenuates lipopolysaccharide-induced lung injury by regulating the balance between angiotensin-converting enzyme and angiotensin-converting enzyme 2 and inhibiting mitogen-activated protein kinase activation.
    Li Y; Zeng Z; Li Y; Huang W; Zhou M; Zhang X; Jiang W
    Shock; 2015 Apr; 43(4):395-404. PubMed ID: 25768373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telmisartan and captopril ameliorate pregabalin-induced heart failure in rats.
    Awwad ZM; El-Ganainy SO; ElMallah AI; Khattab MM; El-Khatib AS
    Toxicology; 2019 Dec; 428():152310. PubMed ID: 31629013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition.
    Jin H; Yang R; Gillett N; Clark RG; Ko A; Paoni NF
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):420-5. PubMed ID: 8583784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of angiotensin-converting enzyme inhibition versus angiotensin II receptor blockade on cardiac sympathetic activity in patients with heart failure.
    Azevedo ER; Mak S; Floras JS; Parker JD
    Am J Physiol Regul Integr Comp Physiol; 2017 Oct; 313(4):R410-R417. PubMed ID: 28679681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study.
    Lee AF; MacFadyen RJ; Struthers AD
    Eur J Heart Fail; 1999 Dec; 1(4):401-6. PubMed ID: 10937954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The brain is a possible target for an angiotensin-converting enzyme inhibitor in the treatment of chronic heart failure.
    Sato T; Yoshimura R; Kawada T; Shishido T; Miyano H; Sugimachi M; Sunagawa K
    J Card Fail; 1998 Jun; 4(2):139-44. PubMed ID: 9730108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic Porphylomonas gingivalis lipopolysaccharide infusion on cardiac dysfunction in mice.
    Matsuo I; Ohnuki Y; Suita K; Ishikawa M; Mototani Y; Ito A; Hayakawa Y; Nariyama M; Morii A; Kiyomoto K; Tsunoda M; Gomi K; Okumura S
    J Oral Biosci; 2021 Dec; 63(4):394-400. PubMed ID: 34757204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous intracerebroventricular injection of Porphyromonas gingivalis lipopolysaccharide induces systemic organ dysfunction in a mouse model of Alzheimer's disease.
    Hayashi K; Hasegawa Y; Takemoto Y; Cao C; Takeya H; Komohara Y; Mukasa A; Kim-Mitsuyama S
    Exp Gerontol; 2019 Jun; 120():1-5. PubMed ID: 30786259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation.
    Plante E; Gaudreau M; Lachance D; Drolet MC; Roussel E; Gauthier C; Lapointe E; Arsenault M; Couet J
    Can J Physiol Pharmacol; 2004 Mar; 82(3):191-9. PubMed ID: 15052285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
    Giles TD; Fisher MB; Rush JE
    Am J Med; 1988 Sep; 85(3B):44-7. PubMed ID: 2844087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
    Khattar RS; Senior R; Soman P; van der Does R; Lahiri A
    Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
    MacFadyen RJ; Lee AF; Morton JJ; Pringle SD; Struthers AD
    Heart; 1999 Jul; 82(1):57-61. PubMed ID: 10377310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure.
    O'Toole L; Stewart M; Padfield P; Channer K
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):988-94. PubMed ID: 9869506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of irbesartan with captopril effects on cardiac hypertrophy and gene expression in heart failure-prone male SHHF/Mcc-fa(cp) rats.
    Carraway JW; Park S; McCune SA; Holycross BJ; Radin MJ
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):451-60. PubMed ID: 10069682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition.
    Al-Shafei AI; Wise RG; Gresham GA; Carpenter TA; Hall LD; Huang CL
    J Physiol; 2002 Jan; 538(Pt 2):555-72. PubMed ID: 11790819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.